Back to Results

A Phase 2b, multicenter, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy, safety, and tolerability of cenerimod in subjects with moderate to severe systemic lupus erythematosus (SLE)

Study category: Bones, Muscles, and Joints

Is this Study for You?

Let's Get Started!

Details
Age

Adult

Eligibility

Diagnosis of SLE made at least 6 months prior to Screening.

Type of Study

Treatment

Location

University of Colorado Hospital

Principal Investigator
Christopher Striebich,  MD, PhD

Christopher Striebich, MD, PhD

Study ID

Protocol Number: 18-2346

More information available at ClinicalTrials.gov: NCT03742037

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers